Skip to main content

Entrada Therapeutics, Inc.

TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689375

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Entrada Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
119
+7 vs. Q4 2025
Shares held
25.5M
+2.68M (+11.8%) vs. Q4 2025
Total value
$321.4M
+$87.3M (+37.3%) vs. Q4 2025
New holders
20
47 more added
Sold out
13
32 more reduced

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 119 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 46 institutionsQ1 2022: 48 institutionsQ2 2022: 38 institutionsQ3 2022: 33 institutionsQ4 2022: 47 institutionsQ1 2023: 53 institutionsQ2 2023: 56 institutionsQ3 2023: 55 institutionsQ4 2023: 62 institutionsQ1 2024: 77 institutionsQ2 2024: 84 institutionsQ3 2024: 97 institutionsQ4 2024: 102 institutionsQ1 2025: 110 institutionsQ2 2025: 107 institutionsQ3 2025: 116 institutionsQ4 2025: 113 institutionsQ1 2026: 119 institutionsQ2 2026: 128 institutions
Value heldQ1 2026: $321.4M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $433.8MQ1 2022: $242.8MQ2 2022: $301.8MQ3 2022: $386.4MQ4 2022: $334.2MQ1 2023: $361.0MQ2 2023: $389.9MQ3 2023: $411.4MQ4 2023: $396.6MQ1 2024: $368.8MQ2 2024: $423.1MQ3 2024: $481.1MQ4 2024: $529.8MQ1 2025: $274.5MQ2 2025: $198.8MQ3 2025: $164.8MQ4 2025: $251.0MQ1 2026: $321.4MQ2 2026: $214.4M
Institutions holding TRDA and their total value by quarter
QuarterHoldersValue
Q2 2026128$214.4M
Q1 2026119$321.4M
Q4 2025113$251.0M
Q3 2025116$164.8M
Q2 2025107$198.8M
Q1 2025110$274.5M
Q4 2024102$529.8M
Q3 202497$481.1M
Q2 202484$423.1M
Q1 202477$368.8M
Q4 202362$396.6M
Q3 202355$411.4M
Q2 202356$389.9M
Q1 202353$361.0M
Q4 202247$334.2M
Q3 202233$386.4M
Q2 202238$301.8M
Q1 202248$242.8M
Q4 202146$433.8M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding TRDA in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Citadel Advisors LLC215,018$2.71M0.00%−77,752−26.6%Reduced
Woodline Partners LP215,977$2.73M0.01%+73,867+52.0%Added
Vanguard Portfolio Management LLC220,494$2.78M0.00%+220,494New
Northern Trust Corp234,992$2.97M0.00%+8,691+3.8%Added
Dimensional Fund Advisors LP324,471$4.09M0.00%+51,093+18.7%Added
Acadian Asset Management LLC333,169$4.20M0.01%+22,336+7.2%Added
Jacobs Levy Equity Management, Inc333,914$4.21M0.02%−28,872−8.0%Reduced
Jones Hill Capital LP374,010$4.72M1.01%+374,010New
Millennium Management LLC519,356$6.55M0.00%+21,661+4.4%Added
Price T Rowe Associates Inc526,043$6.64M0.00%+198,620+60.7%Added
State Street Corp533,798$6.74M0.00%+25,009+4.9%Added
Geode Capital Management, LLC667,347$8.42M0.00%+27,400+4.3%Added
StepStone Group LP761,277$9.61M4.63%00.0%Unchanged
Wellington Management Group LLP1,034,782$13.1M0.00%−9,976−1.0%Reduced
Vanguard Capital Management LLC1,256,013$15.9M0.00%+1,256,013New
TCG Crossover Management, LLC2,287,500$28.9M0.83%+199,108+9.5%Added
BlackRock, Inc.2,358,793$29.8M0.00%+211,533+9.9%Added
5AM Venture Management, LLC4,056,379$51.2M14.21%00.0%Unchanged
Baker Bros. Advisors LP5,072,730$64.0M0.37%00.0%Unchanged
Algert Global LLC0$00.00%−128,611−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−110,942−100.0%Sold out
Los Angeles Capital Management LLC0$00.00%−45,952−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−21,871−100.0%Sold out
Quest Partners LLC0$00.00%−15,629−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−14,017−100.0%Sold out
Walleye Capital LLC0$00.00%−13,534−100.0%Sold out
Magnetar Financial LLC0$00.00%−13,373−100.0%Sold out
Intech Investment Management LLC0$00.00%−11,929−100.0%Sold out
Axq Capital, LP0$00.00%−10,650−100.0%Sold out
Amalgamated Bank0$00.00%−894−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−150−100.0%Sold out
Covestor Ltd0$00.00%−99−100.0%Sold out
Vanguard Group Inc––––Not filed